Premier Research Expands its Medical Device Operations to the United States

Article

Company News Release

PHILADELPHIA, March 11 /PRNewswire/-Premier Research Group Limited, the international clinical services group, is pleased to announce that it has expanded their medical device operations to include full coverage in the United States. Their dedicated medical device group has been offering clinical trials services in Europe since 1997 and is considered an industry leader for managing medical device trials and support services.

"Our clients have requested expanded medical device services, and we are committed to responding to these needs," explained Premier Research Group COO Dr. Troy McCall. "Providing both US and EU medical devices services is a strategic focus for our company and this will strengthen our ability to respond to customer's needs as well as offer a broader range of services for the global market."

U.S. medical device operations will be overseen by Efraim Roe Kozorovitsky, Executive Director, Medical Devices, and a 4-year veteran of the company. Mr. Roe has relocated from Switzerland to the United States. "Since July 2008, we have been establishing the infrastructure for our capabilities in the U.S. and today we are pleased to announce that we have the expertise in place to deliver the same quality that we have been providing in Europe for the past ten years. I look forward to growing this group," he commented.

About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.